Tobias Bergauer

1.0k total citations
11 papers, 650 citations indexed

About

Tobias Bergauer is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Tobias Bergauer has authored 11 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Tobias Bergauer's work include RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and RNA Research and Splicing (3 papers). Tobias Bergauer is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and RNA Research and Splicing (3 papers). Tobias Bergauer collaborates with scholars based in Switzerland, Germany and United States. Tobias Bergauer's co-authors include Buu P. Tu, S. Frank Yan, Yingyao Zhou, Chih-Yuan Chiang, Sumit K. Chanda, Renate König, Anthony P. Orth, Paul DeJesus, Angélica Romero and Sriram Sridhar and has published in prestigious journals such as PLoS ONE, Nature Methods and British Journal of Clinical Pharmacology.

In The Last Decade

Tobias Bergauer

9 papers receiving 636 citations

Peers

Countries citing papers authored by Tobias Bergauer

Since Specialization

Citations

This map shows the geographic impact of Tobias Bergauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Bergauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Bergauer more than expected).

Fields of papers citing papers by Tobias Bergauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Bergauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Bergauer. The network helps show where Tobias Bergauer may publish in the future.

Co-authorship network of co-authors of Tobias Bergauer

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Bergauer. A scholar is included among the top collaborators of Tobias Bergauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Bergauer. Tobias Bergauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Comparison of single-cell RNA-seq methods to enable transcriptome profiling of neutrophils in clinical samples 2025 ·Cell Reports Methods ·Klas Hatje, Kim Schneider, Sabrina Danilin, (unknown), Nicolas Giroud, (unknown), Daniel Marbach, Philip Knuckles, Tobias Bergauer, Matteo M. E. Metruccio, (unknown), Jitao David Zhang, Marc Sultan, Eugene Bell	0
2	Identification of Natural Antisense Transcripts in Mouse Brain and Their Association With Autism Spectrum Disorder Risk Genes 2021 ·Frontiers in Molecular Neuroscience ·(unknown), Geoffrey Fucile, Roland Schmucki, Nicolas Giroud, Tobias Bergauer, Benjamin J. Hall	0
3	A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier 2018 ·British Journal of Clinical Pharmacology ·(unknown), Andreas Guenther, Birgit Jaber, Paul Jordan, (unknown), (unknown), Yumi Cleary, Nicolas Frances, Tobias Bergauer, Katja Heinig, Heidemarie Kletzl, Anne Marquet, Hasane Ratni, Agnès Poirier, Lutz Müller, Christian Czech, Omar Khwaja	74
4	Longitudinal characterization of biomarkers for spinal muscular atrophy 2017 ·Annals of Clinical and Translational Neurology ·Leo H. Bonati, Štefan Holiga, Nicole Hellbach, Céline Risterucci, Tobias Bergauer, (unknown), Patricia Hafner, (unknown), Oliver Bieri, Irene Gerlach, Anne Marquet, Omar Khwaja, Fabio Sambataro, Alessandro Bertolino, Juergen Dukart, Arne Fischmann, Dirk Fischer, Christian Czech	40
5	Drug Target Identification and Validation: Global Pharmaceutical Industry Experts on Challenges, Best Strategies, Innovative Precompetitive Collaboration Concepts, and Future Areas of Industry Precompetitive Research and Development 2016 ·Therapeutic Innovation & Regulatory Science ·Tobias Bergauer, (unknown), Laurent Essioux, Olivia Spleiss	4
6	HepG2/C3A 3D spheroids exhibit stable physiological functionality for at least 24 days after recovering from trypsinisation 2013 ·Toxicology Research ·Krzysztof Wrzesinski, Maria Chiara Magnone, (unknown), (unknown), Tobias Bergauer, María Bobadilla, Marcel Gubler, Jacques Mizrahi, (unknown), Christina Møller Andreasen, (unknown), (unknown), (unknown), Ove B. Schaffalitzky de Muckadell, Stephen J. Fey	47
7	Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression 2012 ·PLoS ONE ·Florence Allantaz, Donavan T. Cheng, Tobias Bergauer, Palanikumar Ravindran, Michel F. Rossier, Martin Ebeling, Laura Badi, Bernhard Reis, Hans Bitter, Matilde D’Asaro, Alberto Chiappe, Sriram Sridhar, Gonzalo Durán Pacheco, Michael E. Burczynski, Denis F. Hochstrasser, Jacky Vonderscher, Thomas Matthes	169
8	Gene expression analysis in biomarker research and early drug development using function tested reverse transcription quantitative real-time PCR assays 2012 ·Methods ·(unknown), Andrea Herold, Tobias Bergauer, Anton Belousov, (unknown), Mark DeMario, (unknown), Leopoldo Luistro, (unknown), (unknown), Mary Ellen Simcox, (unknown), Xuefeng Yin, Hua Zhong, Maja Weisser	14
9	Analysis of Putative miRNA Binding Sites and mRNA 3′ Ends as Targets for siRNA-Mediated Gene Knockdown 2009 ·Oligonucleotides ·Tobias Bergauer, (unknown), Eric Lader, (unknown), (unknown), Wolfgang Bielke	11
10	Insights into Effective RNAi Gained from Large-Scale siRNA Validation Screening 2007 ·Oligonucleotides ·(unknown), Tobias Bergauer, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	62
11	A probability-based approach for the analysis of large-scale RNAi screens 2007 ·Nature Methods ·Renate König, Chih-Yuan Chiang, Buu P. Tu, S. Frank Yan, Paul DeJesus, Angélica Romero, Tobias Bergauer, Anthony P. Orth, (unknown), Yingyao Zhou, Sumit K. Chanda	229

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact